|
 |
Latest news
24 July 2009
Australian medicines makers will miss share of $150 billion export market
AUSTRALIAN generic medicine manufacturers will miss a share of the $150 billion export market during the next six years, because the Government will not take steps to secure a part of this important export market.
The Government announced yesterday it has obtained advice from the Solicitor-General who has determined that it is not possible to make the amendments proposed by GMiA to open up this export market.
The Government is not prepared to share the contents of the Solicitor-General advice.
It is disappointing for the development of the generic medicines industry in Australia. The Government's decision will have a detrimental impact on growth of member companies in Australia.
Medicines that could be made in Australia, by Australian workers, to generate export dollars for the Australian economy will not be made. These medicines will need to be made offshore.
GMiA maintains that the proposed changes would never have adversely impacted the patent rights of originators. Unfortunately this decision adversely impacts the employment and trade prospects for Australians.
Kate Lynch
Chief Executive Officer